e-learning
resources
Milan 2017
Tuesday, 12.09.2017
Insight into the pathogenesis of emphysema and pneumonia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Incomplete angiopoietin-2 knockdown does not confer protection in murine pneumococcal pneumonia
B. Gutbier (Berlin, Germany)
Source:
International Congress 2017 – Insight into the pathogenesis of emphysema and pneumonia
Session:
Insight into the pathogenesis of emphysema and pneumonia
Session type:
Thematic Poster
Number:
3937
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Gutbier (Berlin, Germany). Incomplete angiopoietin-2 knockdown does not confer protection in murine pneumococcal pneumonia. 3937
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Downregulation of RTI
40
/T1α protein in pneumococcal pneumonia
Source: Eur Respir J 2004; 24: Suppl. 48, 719s
Year: 2004
Galectin-3 reduces the severity of pneumococcal pneumonia by augmenting neutrophil function
Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host
Year: 2008
Protective efficacy and antigenicity of influenza HA-VLPs in a murine model of postinfluenza bacterial pneumonia.
Source: International Congress 2019 – Clinical challenges in respiratory infection
Year: 2019
Role of angiopoietins Ang-1 and Ang-2 for the development of acute lung injury in pneumococcal pneumonia
Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia
Year: 2011
Chlamydia pneumoniae enhances infection with Haemophilus influenzae, up-regulates TLR2-expression in human lung tissue and leads to enhanced chemokine production after coinfection – a possible mechanism for COPD exacerbations
Source: Annual Congress 2008 - New diagnostic methods in viral and atypical infections
Year: 2008
Heterologous infection causes pneumonia and impairs alveolar macrophage function in mice
Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host
Year: 2008
Impact of nasopharyngeal pneumococcal colonization on dendritic cell-dependent protective immunity against invasive pneumococcal disease in mice
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016
Airway administration of therapeutic antibody (tAb) confers higher protection than parenteral administration in a murine model of acute lung infection
Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies
Year: 2018
Pulmonary fibrosis in mice increases susceptibility to pneumococcal pneumonia and bacteremia
Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease
Year: 2021
Pulmonary immunostimulation with macrophage-activating lipopeptide-2 in influenza-A-virus infected mice increased survival of subsequent pneumococcal pneumonia
Source: Annual Congress 2012 - Hot topics in respiratory infections
Year: 2012
Vaporized perfluorocarbon confers protection against acute lung injury by inhibiting MMP-9 expression without protective effects in other organs
Source: Annual Congress 2010 - Acute respiratory failure
Year: 2010
PcrV antibody prophylaxis in combination with antibiotic therapy reduces lung injury and improves survival in pseudomonas aeruginosa infected mice
Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections
Year: 2011
Influence of the infecting serotype on the development of complications in bacteriemic pneumococcal pneumonia with high inflammatory response
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020
Impact of nasopharyngeal pneumococcal colonization on protective immunity against S. pneumoniae in mice
Source: International Congress 2015 – Advances from translational research in respiratory infections
Year: 2015
Syndecan-1 attenuates lung injury during influenza infection by activating survival signals via c-Met
Source: Lung Science Conference 2015
Year: 2015
Targeting PI3Kd attenuates influenza virus-induced inflammation in a murine model of asthma exacerbation
Source: International Congress 2017 – Infection and exacerbation science
Year: 2017
The endogenous antibiotic CRAMP is induced during pneumonia
Source: Eur Respir J 2004; 24: Suppl. 48, 555s
Year: 2004
Emergence of an immunosuppressive neutrophil phenotype during pneumococcal lung co-infection with influenza A virus
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019
Performance of the binax NOW
Streptococcus pneumoniae
urinary antigen assay among children with underlying pulmonary diseases in the absence of acute pneumococcal infection
Source: Eur Respir J 2004; 24: Suppl. 48, 391s
Year: 2004
Enhance protection against nasopharyngeal carriage of
Streptococcus pneumoniae
elicited by live recombinant attenuated oral salmonella vaccines with PspA‘ and PsaA
Source: Annual Congress 2009 - Mechanisms of infection: what's new?
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept